ATG13 anticorps (C-Term)
Aperçu rapide pour ATG13 anticorps (C-Term) (ABIN783663)
Antigène
Voir toutes ATG13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse, rat
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 15 amino acid peptide near the carboxy terminus of human ATG13
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the antibody (in aliquots) at -20 °C.
-
-
- ATG13 (Autophagy Related 13 (ATG13))
-
Autre désignation
- KIAA0652
-
Sujet
- Autophagy, the process of bulk degradation of cellular proteins through an autophagosomic-lysosomal pathway is important for normal growth control and may be defective in tumor cells. It is involved in the preservation of cellular nutrients under starvation conditions as well as the normal turnover of cytosolic components. This process is negatively regulated by TOR (Target of rapamycin) through phosphorylation of autophagy protein ATG1. ATG13 forms a complex with ULK1 and ULK2, the mammalian homologs of ATG1, and with FIP200. This complex is a target of TOR phosphorylation under normal conditions, inhibition of TOR by rapamycin or leucine deprivation leads to dephosphorylation of ATG13, ULK1 and ULK2, which then leads to autophagy. Knockdown of ATG13 inhibits autophagosome formation.Synonyms: UPF0630 protein KIAA0652
-
ID gène
- 9776
-
NCBI Accession
- NP_001136145
-
UniProt
- O75143
-
Pathways
- Signalisation PI3K-Akt, Autophagy
Antigène
-